These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25536893)

  • 41. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.
    Lange-Asschenfeldt C; Grohmann R; Lange-Asschenfeldt B; Engel RR; Rüther E; Cordes J
    J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Drug therapy in child and adolescent psychiatry in Germany between ethical as well as social and legal conflicts].
    Gerlach M; Warnke A
    Z Kinder Jugendpsychiatr Psychother; 2016; 44(4):249-55. PubMed ID: 27434686
    [No Abstract]   [Full Text] [Related]  

  • 43. Placebo effect in child and adolescent psychiatric trials.
    Parellada M; Moreno C; Moreno M; Espliego A; de Portugal E; Arango C
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):787-99. PubMed ID: 22030230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Critical Commentary on the 2017 AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology.
    de Leon J
    Pharmacopsychiatry; 2018 Jan; 51(1-02):63-68. PubMed ID: 28922669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TDM in Saxonia (Germany).
    Niederhofer H
    Pharmacopsychiatry; 2013 Jun; 46(4):161. PubMed ID: 23737192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Value and actuality of the prescription information for therapeutic drug monitoring of psychopharmaceuticals: a comparison with the medico-scientific evidence.
    Ulrich S; Hiemke C; Laux G; Müller-Oerlinghausen B; Havemann-Reinecke U; Riederer P; Zernig G; Baumann P;
    Pharmacopsychiatry; 2007 May; 40(3):121-7. PubMed ID: 17541888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Traditional and alternative research designs and methods in clinical pediatric psychopharmacology.
    Fava M
    J Am Acad Child Adolesc Psychiatry; 1996 Oct; 35(10):1292-303. PubMed ID: 8885583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design and methods of the 'monitoring outcomes of psychiatric pharmacotherapy' (MOPHAR) monitoring program - a study protocol.
    Simoons M; Ruhé HG; van Roon EN; Schoevers RA; Bruggeman R; Cath DC; Muis D; Arends J; Doornbos B; Mulder H
    BMC Health Serv Res; 2019 Feb; 19(1):125. PubMed ID: 30764821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The new German drug market law AMNOG from a child and adolescent psychiatry perspective].
    Dittmann RW
    Nervenarzt; 2016 Apr; 87(4):367-75. PubMed ID: 26992908
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic drug monitoring in Italian psychiatry.
    Conca A; Schmidt E; Pastore M; Hiemke C; Duffy D; Giupponi G
    Pharmacopsychiatry; 2011 Sep; 44(6):259-62. PubMed ID: 21959788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Psychopharmacology in the psychogeriatric domain: current data, problems, perspectives].
    Lima CA; Eap CB; Baumann P
    Rev Med Suisse Romande; 2000 Feb; 120(2):131-6. PubMed ID: 10748699
    [No Abstract]   [Full Text] [Related]  

  • 52. [Therapeutic drug monitoring: A pharmacotherapeutic tool in psychiatry].
    Stephan PL; Etzensberger M; Jaquenoud Sirot E
    Praxis (Bern 1994); 2006 Apr; 95(17):671-8. PubMed ID: 16686323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Scientific methodology and psychopharmacology].
    Elie R; Ohayon M
    Ann Med Psychol (Paris); 1992; 150(2-3):192-4; discussion 194-5. PubMed ID: 1343517
    [No Abstract]   [Full Text] [Related]  

  • 54. Ethical issues in child psychopharmacology research and practice: emphasis on preschoolers.
    Spetie L; Arnold LE
    Psychopharmacology (Berl); 2007 Mar; 191(1):15-26. PubMed ID: 17279378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Therapeutic and cosmetic psychopharmacology. Risks and limits].
    Echarte Alonso LE
    Cuad Bioet; 2009; 20(69):211-30. PubMed ID: 19507923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The AMUP study for drug surveillance in psychiatry - a summary of inpatient data.
    Grohmann R; Hippius H; Helmchen H; Rüther E; Schmidt LG
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S16-26. PubMed ID: 15052511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of European regulatory policies on psychotropic drug prescribing patterns.
    Garattini S; Bertele' V
    Int Rev Psychiatry; 2005 Jun; 17(3):199-204. PubMed ID: 16194791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical issues in child and adolescent psychopharmacology.
    Gadow KD
    J Consult Clin Psychol; 1991 Dec; 59(6):842-52. PubMed ID: 1774369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sense and Sensibility When Prescribing 'Off-Label' to Psychiatric Patients.
    Baldwin DS; Tiwari N; Gordon R
    Curr Pharm Des; 2015; 21(23):3276-9. PubMed ID: 26088118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Editorial: Off-label Treatments for Mental Health: Inappropriate or Unavoidable? A Special Issue to Help Get Through the Maze.
    Rolland B; Amad A
    Curr Pharm Des; 2015; 21(23):3274-5. PubMed ID: 26238988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.